IMCC
Price
$0.16
Change
-$0.02 (-11.11%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.48M
Intraday BUY SELL Signals
ZSTK
Price
$4.04
Change
-$0.00 (-0.00%)
Updated
Jun 23, 03:55 PM (EDT)
Capitalization
9.82M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMCC vs ZSTK

IMCC vs ZSTK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMCC vs. ZSTK commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Hold and ZSTK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (IMCC: $0.17 vs. ZSTK: $4.04)
Brand notoriety: IMCC and ZSTK are both not notable
IMCC represents the Pharmaceuticals: Generic, while ZSTK is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: IMCC: 32% vs. ZSTK: 28%
Market capitalization -- IMCC: $1.56M vs. ZSTK: $9.82M
IMCC [@Pharmaceuticals: Generic] is valued at $1.56M. ZSTK’s [@Investment Managers] market capitalization is $9.82M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $163.27B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B. The average market capitalization across the [@Investment Managers] industry is $9.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 1 FA rating(s) are green whileZSTK’s FA Score has 0 green FA rating(s).

  • IMCC’s FA Score: 1 green, 4 red.
  • ZSTK’s FA Score: 0 green, 5 red.
According to our system of comparison, ZSTK is a better buy in the long-term than IMCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 4 TA indicator(s) are bullish while ZSTK’s TA Score has 3 bullish TA indicator(s).

  • IMCC’s TA Score: 4 bullish, 4 bearish.
  • ZSTK’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMCC is a better buy in the short-term than ZSTK.

Price Growth

IMCC (@Pharmaceuticals: Generic) experienced а -33.91% price change this week, while ZSTK (@Investment Managers) price change was -17.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.70%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was +8.31%.

The average weekly price growth across all stocks in the @Investment Managers industry was -2.28%. For the same industry, the average monthly price growth was -2.46%, and the average quarterly price growth was -8.13%.

Reported Earning Dates

ZSTK is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.70% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Investment Managers (-2.28% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZSTK($9.82M) has a higher market cap than IMCC($1.48M). ZSTK YTD gains are higher at: -35.463 vs. IMCC (-87.590). IMCC has higher annual earnings (EBITDA): -8.75M vs. ZSTK (-151.12M). ZSTK has more cash in the bank: 1.98M vs. IMCC (1M). ZSTK has less debt than IMCC: ZSTK (3.55M) vs IMCC (15M). IMCC has higher revenues than ZSTK: IMCC (50.9M) vs ZSTK (36.1M).
IMCCZSTKIMCC / ZSTK
Capitalization1.48M9.82M15%
EBITDA-8.75M-151.12M6%
Gain YTD-87.590-35.463247%
P/E RatioN/AN/A-
Revenue50.9M36.1M141%
Total Cash1M1.98M51%
Total Debt15M3.55M423%
FUNDAMENTALS RATINGS
IMCC: Fundamental Ratings
IMCC
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMCCZSTK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 29 days ago
83%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IMCC
Daily Signal:
Gain/Loss:
ZSTK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTW13.250.08
+0.61%
Manitowoc Company (The)
AXGN44.950.11
+0.25%
Axogen
XPL0.81N/A
+0.20%
Solitario Resources Corp
NWGL0.24N/A
-2.00%
CL Workshop Group Limited
SNN29.39-0.69
-2.29%
Smith & Nephew plc

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and TXMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and TXMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
-4.75%
TXMD - IMCC
25%
Poorly correlated
+3.59%
TRLV - IMCC
23%
Poorly correlated
-9.70%
CRON - IMCC
23%
Poorly correlated
-2.21%
SCYX - IMCC
22%
Poorly correlated
-6.05%
SNDL - IMCC
22%
Poorly correlated
-1.06%
More

ZSTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZSTK has been loosely correlated with SNDL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZSTK jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZSTK
1D Price
Change %
ZSTK100%
N/A
SNDL - ZSTK
37%
Loosely correlated
-1.06%
ACET - ZSTK
34%
Loosely correlated
+1.60%
SXTC - ZSTK
26%
Poorly correlated
+7.17%
IMCC - ZSTK
26%
Poorly correlated
-4.75%
RMTI - ZSTK
24%
Poorly correlated
+4.56%
More